20171026|IPIX|85342|0|272236|O 31.34%
copy of a PM sent
20171026|IPIX|85342|0|272236|O 31.34%
copy of a PM sent to another P2O investor ..
Sent On: 10/26/2017 4:42:08 PM
AvatarSent By: 4kids
watch to see what gets marked tonight
imo as i've noted to drano for weeks now .. they (NR) are stuck
they had 2 choices because the 3rd (stall) doesn't work with news coming out consistently from mgmt which is en route
so the 2 choices were to reset 52 week low and pray like hell as if by magic some investors would actually sell out ..
clearly that gamble undertaken in May .. has been an EPIC fail .. based on *volume* decreasing .. they came within 2c of 63c and 3c of resetting ..
today's PR added to this week's other PR .. imo made them face the fact they have to do another (attempted) controlled take up (other choice) .. this one imo
will be telling where stopped out at .. last 2 were stopped out at 1.08
the problem with trying *this* controlled take up .. is the clock and calendar are working against them and imo they know it
note where VERT got placed early on today after playing decoy for CDEL .. 79c
it would not have surprised me if they *closed* IPIX @ 79c .. but it's only Thursday
this news should be digested .. which makes tomorrow the key for what imo comes next
if they show low to no volume and maintain the PPS say from 72c to 78c
imo it is quite possible that next week we see a quick *run/take up* to try and scrounge some shares from traders
but since they spent so much *capital* trying to not do a 3rd take up since Aug
it's quite possible they lose their predetermined price point (imo about 95c max)
and that is the dilemma they face ..
there is nothing i post .. they haven't already calculated imo .. and i do understand concerns ..
but i'm at the point of my life where i recognize .. legit bid support provides speed bumps against them .. ask hits aid and abet them .. and pretty much every trade today was mirrored .. imo at least 2x .. which brings me back to what they have to mark tonight
it should be above 30% .. if it's below .. imo some of today's *oddly timed* buying frenzies .. were done for *D* .. NRs' dilution specific to daily reg sho %s having to be reported
if it's significantly higher .. imo it proves mgmt's awareness of timing going forward .. and NRs' seriously UPSIDE position re: IPIX
NRs' worst NITEmare .. is an aware and savvy mgmt team that can deliver the goods (ability to execute) coupled with actual retail investors who understand exactly what is being done .. and why
====
4kids
7
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Ritchie's Recognition: An Ongoing Leadership Journey When leadership is genuine, it resonates through the ranks all the way to the community. That's exactly what Meredith Ritchie, EVP at Alliant Credit Union, has been doing—and it shows as she nabs the Chicago Titan 100 accolade yet again in 2027. These folks at Titan 100 don’t hand out participation trophies;...
Continue Reading
Robotic Mowers Meet Tech Mastery In the never-ending quest to tech-up every corner of our lives, robotic mowers are carving out their patch of the market—thanks in no small part to Fibocom and Suntek teaming up like a couple of tech-savvy gardeners. Here’s the lowdown: In Munich, during the electronica 2026 show, these two companies showcased how they’re making...
Continue Reading
From Idea to Relaxed Tails: Enter THE PAW FREE SCRATCHER Strolling along the bustling streets of Pittsburgh, it's the kind of idea that hits you when you least expect it. The endless days spent scratching your furry buddy, only to realize you're the one more tuckered out. Some inventive soul from Puyallup, Washington, decided to tackle this furry fatigue head-on. They've...
Continue Reading
Analyzing Telecom Argentina's Financial Turmoil Telecom Argentina's nine-month stretch of 2026 wasn’t a smooth sail by any stretch. The powerhouse saw a consolidated net loss of P$56,615 million for the third quarter while bagging a net income of P$862,959 million across the broader period. Talk about volatility. It's a classic case of juggling financial fire,...
Continue Reading
Breaking Free from Animal-Derived Components It feels like every biotech firm out there wants to ditch animal components these days, and TheWell Bioscience is no exception. With their new RocketCell™ S1, S2, and S3 supplements, they're diving headlong into the trend of animal origin-free (AOF) cell culture solutions. It's a smart move for researchers frustrated by the...
Continue Reading
Battle-tested Expertise Joins SVP's Ranks Whatever way you slice it, personnel like Shigesuke Kashiwagi don't come around every day. When an outfit like Strategic Value Partners welcomes a heavyweight like him as a Senior Advisor, it's definitely worth a closer look. With decades of financial machinations under his belt, including pivotal roles at Nomura and Schroders,...
Continue Reading
Seeking Serenity: The Essence of Kayon Valley Caught in the whirlwind of modern life, couples often find themselves yearning for tranquility—a place to reconnect away from the rigmarole. Enter The Kayon Valley Resort in Ubud, Indonesia, newly crowned as the Best Honeymoon Resort 2026. This spot isn't just another pin on the map, it’s a refuge where wellness and...
Continue Reading
Pentixapharm and Eckert & Ziegler's Extended Bond Play Fresh off the Berlin newswire, Pentixapharm Holding AG made a bold move with Eckert & Ziegler SE (EZAG). This isn't your everyday handshake, folks. We're talking about extending a 4.00% convertible bond from 2027 all the way out to 2030. There's a twist: the interest rate's ticking up to 6.00% starting in 2027. So,...
Continue Reading
Navigating the Turbulent Waters of Note Exchanges Well folks, it looks like JELD-WEN Holding, Inc. is making waves again. The company has decided to shake things up a bit with a new twist on the note exchange comedy script. They’re altering the terms of the late exchange consideration for their outstanding 4.875% Senior Notes due 2027, making the latecomers to the party...
Continue Reading
Thriving in a Complex Energy World You know, for Frontera Energy Corporation, it's not just about tossing around tanker loads of cash—it’s about working those numbers into something real. Their Q3 2026 gives us a peep into how they’re keeping the hot iron pressed against opportunity. With a net income of $11.7 million and adjusted EBITDA jumping 16% to top $34.8...
Continue Reading
Top 5 Most Recently Viewed Articles
Tezspire’s Role in Managing Chronic Rhinosinusitis Recent breakthroughs in the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) show promising results with Tezspire (tezepelumab-ekko), a groundbreaking therapy. This innovative medication has demonstrated remarkable efficacy in alleviating symptoms and reducing the severity of nasal polyps, marking a...
Continue Reading
eInfochips Earns Recognition in Quality Engineering Services eInfochips, a renowned provider of product engineering and digital transformation services, recently announced its place in the notable Gartner Market Guide for Quality Engineering Services. This achievement highlights eInfochips' dedication to delivering exceptional quality and innovative solutions to clients...
Continue Reading
Opportunity for Investors in DoubleVerify Holdings, Inc. Rosen Law Firm, a well-respected investor rights law firm, has announced a significant opportunity for purchasers of common stock of DoubleVerify Holdings, Inc. (NYSE: DV). This notification is aimed at those who bought shares between November 10, 2023, and February 27, 2025. It is crucial for these investors to be...
Continue Reading
Fingrid's Commitment to a Sustainable Future Fingrid, as Finland's transmission system operator, is dedicated to ensuring the reliability and sustainability of electricity supply throughout the nation. As part of its commitment to transparency and accountability, the company publishes detailed Management Reviews every six months, providing insights into its financial and...
Continue Reading
Decisions at Coloplast A/S Annual General Meeting Recently, Coloplast A/S convened its Annual General Meeting (AGM), where significant resolutions were adopted that will shape the company's future. This gathering marked an important event for stakeholders, emphasizing the company's dedication to transparency and responsible governance. Approval of Financial Reports One of...
Continue Reading